Etiopathogenesis of inflammatory glaucoma. Treatment aspects
DOI:
https://doi.org/10.52556/2587-3873.2022.1(92).04Keywords:
inflammatory glaucoma, uveitis, intraocular pressureAbstract
Inflammatory (uveitic) glaucoma is a type of secondary glaucoma, which occurs due to eye inflammation, is characterized by a persistent or periodic increase in intraocular pressure (IOP) and glaucomatous lesions of the optic nerve. The mechanism by which inflammation increases IOP is not yet fully elucidated, and pathogenic pathways remain shrouded in mystery. The consequences of the disease lead to a drastic decrease in visual acuity and invalidation of young, able-to work patients. The treatment of this type of glaucoma will be personalized for each patient, aiming at the administration of standard antiglaucomatous remedies, performing surgeries if indicated and applying new therapeutic trends. This article will be useful for the clinician to help a patient with inflammatory glaucoma. It aims to elucidate the etiopathogenesis and key treatment elements. Being a review of literature, it will be helpful in determining the cause, understanding all known pathogenetic pathways and making a therapeutical decision. All this steps are designed to preserve visual function at the best possible level.
References
1. Bodh s. A., et al. , inflammatory glaucoma, oman J ophthalmol. 2011 Jan-Apr; 4(1): 3-9. https://doi.org/10.4103/0974-620X.77655
2. Kalogeropoulos, d., et al. Pathogenesis of uveitic glaucoma, J curr glaucoma Pract. 2018 sep-dec; 12(3): 125-138. https://doi.org/10.5005/jp-journals-10028-1257
3. егоров е.А., пархоменко е.г., петренко о.в., и др., клиника глаукомы. межнациональное руководство по глаукоме. стр. 54-64. москва, 2016.
4. sherman E.R., cafiero-chin m. , overcoming diagnostic and treatment challenges in uveitic glaucoma, clin Exp optom. 2019 mar;102(2):109-115. https://doi.org/10.1111/cxo.12811
5. ldaas K., et al. infections and glaucoma, surv ophthalmol. 2021 sep 4; s0039-6257(21)00181-8. https://doi.org/10.1016/j.survophthal.2021.08.009
6. Baudouin ch., et al. inflammation in glaucoma: From the back to the front of the eye, and beyond, Prog Retin Eye Res. 2021 Jul; 83:100916. https://doi.org/10.1016/j.preteyeres.2020.100916
7. d cela, F Brignole-Baudouin, A labbé, c Baudouin, The trabecular meshwork in glaucoma: An inflammatory trabeculopathy? Fr ophtalmol. 2021 nov;44(9): e497-e517. https://doi.org/10.1016/j.jfo.2021.09.001
8. Jones nP., Fuch›s hetrochromic uveitis: An update. surv opthalmol. 1993; 37:253-72. https://doi.org/10.1016/0039-6257(93)90009-V
9. Bonfiolli AA, orefice F., sarcoidosis, semin ophthalmol. 2005; 20:177-82. https://doi.org/10.1080/08820530500231938
10. Kimura sJ, hogan mJ, Thygeson P., Fuch›ssyndrome of heterochromic cyclitis, AmA Arch ophthalmol. 1955; 54:179-86. https://doi.org/10.1001/archopht.1955.00930020181003
11. Hirose S, Ohno S, Matsuda H., hlA Bw 54 and glaucomocyclitic crisis. Arch ophthalmol. 1985; 103:1837-9. https://doi.org/10.1001/archopht.1985.01050120071023
12. Pillai cT, dua hs, Azuara-Blanco A, sarhan AR., Evaluation of corneal endothelium and keratic precipitates by specular microscopy in anterior uveitis. Br J ophthalmol. 2000; 84:1367-71. https://doi.org/10.1136/bjo.84.12.1367
13. Quarta l, corrado A, melillo n., Juvenile idiopathic arithritis. An update on clinical and therapeutic approaches. Ann ital med int. 2005;20:211-7.
14. Allingham RR, damji K, Freedman s, moroi s, shafranor g, editors. steroid induced glaucoma. shields textbook of glaucoma. 5th ed. Baltimore: lippincott Williams and Wilkins; 2005.
15. Netland PA, denton nc., uveitic glaucoma. contemp ophthalmol. 2006; 5:1-6.
16. Kanda T, shibata m, Taguchi m, herbert hm, Viswanathan A, Jackson h., Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. Br J ophthalmol. 2014; 98:932-936. https://doi.org/10.1136/bjophthalmol-2013-304416
17. sen hn, drye lT, goldstein dA et al., multicenter uveitis steroid Treatment (musT) Trial Research group. hypotony in patients with uveitis: the multicenter uveitis steroid treatment (musT) trial. ocul immunol inflamm. 2012;20((2)):104--112. https://doi.org/10.3109/09273948.2011.647228
18. Aman R, Engelhard sB, Bajwa A, et al., ocular hypertension and hypotony as determinates of outcomes in uveitis. clin ophthalmol. 2015 dec 7;9::2291--98. https://doi.org/10.2147/OPTH.S90636
19. horsley m, chen T., The use of prostaglandin analogs in the uveitic patient. semin ophthalmol. 2011; 26(4-5):285-9.
https://doi.org/10.3109/08820538.2011.588650
20. horai R, caspi RR., cytokines in autoimmune uveitis. J interferon cytokine Res. 2011; 31::733--744. https://doi.org/10.1089/jir.2011.0042
21. Abu El-Asrar Am, struyf s, Kangave d, et al., cytokine and cXc chemokine expression patterns in aqueous humor of patients with presumed tuberculous uveitis. cytokine. 2012; https://doi.org/10.1016/j.cyto.2012.04.030
22. ohira s, inoue T, iwao K, et al., Factors influencing Aqueous Proinflammatory cytokines and growth Factors in uveitic glaucoma. Plos one. 2016 15; Jan;11(1): e0147080. https://doi.org/10.1371/journal.pone.0147080
23. hirooka K, shiraga F., Potential role for angiotensin converting enzyme inhibitors in the treatment of glaucoma. clin ophthalmol. 2007.
24. oguz E, Alasehirli B, Pehlivan Y, et al., Association between Rho-kinase (RocK2) gene polymorphisms and Behçet's disease. Transl Res. 2012; https://doi.org/10.1016/j.trsl.2012.08.002
25. Sorkhabi R. et al. Oxidative dnA damage and total antioxidant status in glaucoma patients. mol Vis. 2011.
26. Razeghinejad mR, Katz lJ., Steroid-induced iatrogenic glaucoma. ophthalmic Res. 2012; https://doi.org/10.1159/000328630
27. lommatzsch, c., et al. uveitic secondary glaucoma, 2018 may;235(5):576-585. https://doi.org/10.1055/a-0573-9598
28. Belkhadir K , Boutimzine n., Tachfouti s. et al., uveitic glaucoma in Behçet's disease: When everything gets complicated, J Fr ophtalmol. 2020 sep;43(7):635-641. https://doi.org/10.1016/j.jfo.2019.12.005
29. Kesay n., et al., current management of uveitis-associated ocular hypertension and glaucoma. surv ophthalmol. Jul-Aug 2020;65(4):397-407. https://doi.org/10.1016/j.survophthal.2019.12.003
30. Kalogeropoulos d., et al., The management of uveitic glaucoma in children. J ophthalmol. 2019 oct 24;49(5):283-293. https://doi.org/10.4274/tjo.galenos.2019.36589
31. Espinosa-Barberi g., et al., surgical management of complicated inflammatory glaucoma. gms ophthalmol cases. 2020 nov 10; 10: doc43. https://doi.org/10.3205/oc000170.
32. huang Z., et al. surgical management in a Patient with complex uveitic glaucoma: A case Report, medicine (Baltimore). 2015 Aug;94(31): e1248. https://doi.org/10.1097/MD.0000000000001248
33. Dhanireddy s, et al., The Ex-PREss glaucoma Filtration device implantation in uveitic glaucoma, ocul immunol inflamm. 2017 dec;25(6):767-774. https://doi.org/10.1080/09273948.2016.1175639
34. Ramdas Wd., et al., Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature, clin Exp ophthalmol. 2019 Jan;257(1):143-151. https://doi.org/10.1007/s00417-018-4156-9
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
